Elderly lung CA patients benefit from aggressive chemo‘Remarkable’ four-month improvement in survival will change practice, researchers say Many NPs lack oncology expertise: studySupervising physicians act as educators for NPs new to oncology. Yondelis approved for relapsed ovarian cancer New drug delivery system: the nanosponge? Radiation-hormone therapy combo best for high-risk prostate cancer Elderly lung cancer patients benefit from aggressive chemo 'Remarkable' four-month improvement in survival will change practice, researchers say Sponge-derived drug extends breast cancer survival Targeted therapy battles late-stage lung cancer Researchers tailor treatment to tumour’s molecular signature Breast density decrease linked with lower cancer risk Tamoxifen vs. raloxifene: Which is best for breast cancer prevention? Followup study further delineates the differences in effectiveness and toxicity between the two selective estrogen receptor modulators First Previous 58 59 60 61 62 Next Last